Solomon Owumi obtained a PhD in Biochemistry from the University of Ibadan in 2008 and was a Shell Petroleum Development Company Scholar as an undergraduate (1995-2000). He had predoctoral training (Indiana University Purdue University: 2006-07) and postdoctoral training (Leland Stanford University: 2011-2015). Dr Owumi was a recipient of the AACR-NCI International Cancer Research Fellowship Awardee in 2010 by the American Association for Cancer Research. He is listed among the two percent of Global Best Scientists in 2023 and has several peer-reviewed publications in reputable scientific journals. Dr. Owumi is a member of the Biochemical Society, Society of Environmental Toxicology and Chemistry (SETAC), and the American Association for Cancer Research (AACR). Dr. Owumi is a Professor of Biochemistry at the University of Ibadan, where he is the Principal Investigator of ChangeLab-Biochem, performing basic science research focused on chemical and drug-induced toxicity and its relationship to biochemical toxicology and chemical carcinogenesis, mentoring students to become innovators in their chosen career fields and serve communities in whatever capacity one is situated. Dr Owumi is a Visiting Research Scholar at the Georgia Institute of Technology. (Most of his publications can be accessed at: https://pubmed.ncbi.nlm.nih.gov/?term=Owumi%20S&sort=date&page=2
John O Olanlokun obtained his B.Sc degree in Biochemistry from Ondo State University, Ado-Ekiti, in 1998. He received his M.Sc in Biochemistry from the University of Ibadan in 2003 and his Ph.D. from the University of Ibadan in 2014. Shortly after his first degree, he joined the services of Ondo State University, Ado-Ekiti (now Ekiti State University) in 2002 as a Graduate Assistant in the Department of Biochemistry and rose to become a lecturer in the department. He served the university meritoriously until 2012. In 2012, he joined the services of the University of Ibadan and rose to become a Senior Lecturer in October 2018. His area of specialization is Membrane Biochemistry and Biotechnology, and he has delved into drug discovery and development for the treatment and prevention of malaria and mitochondrial dysfunction. He has unequivocally purified and characterized some natural products with therapeutic potential in the treatment of resistant malaria in mouse models. Currently, he is working on mitochondrial dynamics in Plasmodium infection and chemotherapy.
